Current Status of Brachytherapy in Cancer Treatment - Short Overview

Overview

Journal J Contemp Brachytherapy

Date 2018 Feb 15

PMID 29441104

Citations 49

Authors

Janusz Skowronek

Affiliations

Soon will be listed here.

Abstract

Cancer incidence and mortality depend on a number of factors, including age, socio-economic status and geographical location, and its prevalence is growing around the world. Most of cancer treatments include external beam radiotherapy or brachytherapy. Brachytherapy, a type of radiotherapy with energy from radionuclides inserted directly into the tumor, is increasingly used in cancer treatment. For cervical and skin cancers, it has become a standard therapy for more than 100 years as well as an important part of the treatment guidelines for other malignancies, including head and neck, skin, breast, and prostate cancers. Compared to external beam radiotherapy, brachytherapy has the potential to deliver an ablative radiation dose over a short period of time directly to the altered tissue area with the advantage of a rapid fall-off in dose, and consequently, sparing of adjacent organs. As a result, the patient is able to complete the treatment earlier, and the risks of occurrence of another cancer are lower than in conventional radiotherapy treatment. Brachytherapy has increased its use as a radical or palliative treatment, and become more advanced with the spread of pulsed-dose-rate and high-dose-rate afterloading machines; the use of new 3D/4D planning systems has additionally improved the quality of the treatment. The aim of the present study was to present short summaries of current studies on brachytherapy for the most frequently diagnosed tumors. Data presented in this manuscript should help especially young physicians or physicists to explore and introduce brachytherapy in cancer treatments.

Citing Articles

Ensemble Learning for Three-dimensional Medical Image Segmentation of Organ at Risk in Brachytherapy Using Double U-Net, Bi-directional ConvLSTM U-Net, and Transformer Network.

Pal S, Singh R, Kumar A J Med Phys. 2025; 49(4):574-582.

PMID: 39926139 PMC: 11801097. DOI: 10.4103/jmp.jmp_160_24.

COMIRI - COMplexity Index of interventional Radiotherapy (brachytherapy) Implants: assessment of procedures based on type, equipment, and team.

Fionda B, Placidi E, Lancellotta V, Rosa E, De Angeli M, Wojcieszek P J Contemp Brachytherapy. 2024; 16(4):306-309.

PMID: 39628818 PMC: 11609858. DOI: 10.5114/jcb.2024.143223.

Melanoma Cells from Different Patients Differ in Their Sensitivity to Alpha Radiation-Mediated Killing, Sensitivity Which Correlates with Cell Nuclei Area and Double Strand Breaks.

Levy O, Altaras A, Binyamini L, Sagi-Assif O, Izraely S, Cooks T Cancers (Basel). 2024; 16(22).

PMID: 39594759 PMC: 11592378. DOI: 10.3390/cancers16223804.

Access to brachytherapy treatment for cervical cancer management in Africa.

Fiagbedzi E, Atuwo-Ampoh V, Ofori I, Nyarko S, Adomako A, Hasford F Clin Transl Radiat Oncol. 2024; 50:100880.

PMID: 39553385 PMC: 11564044. DOI: 10.1016/j.ctro.2024.100880.

Dose escalation with stereotactic body radiotherapy for cervical cancer treatment.

Turna M, Rzazade R, Kucukmorkoc E, Kucuk N, Canoglu M, Caglar H BMC Cancer. 2024; 24(1):1281.

PMID: 39407149 PMC: 11481774. DOI: 10.1186/s12885-024-13017-8.

References

Stewart A, Parashar B, Patel M, OFarrell D, Biagioli M, Devlin P . American Brachytherapy Society consensus guidelines for thoracic brachytherapy for lung cancer. Brachytherapy. 2015; 15(1):1-11. DOI: 10.1016/j.brachy.2015.09.006. View

Ott O, Strnad V, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T . GEC-ESTRO multicenter phase 3-trial: Accelerated partial breast irradiation with interstitial multicatheter brachytherapy versus external beam whole breast irradiation: Early toxicity and patient compliance. Radiother Oncol. 2016; 120(1):119-23. DOI: 10.1016/j.radonc.2016.06.019. View

Potter R, Georg P, Dimopoulos J, Grimm M, Berger D, Nesvacil N . Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother Oncol. 2011; 100(1):116-23. PMC: 3165100. DOI: 10.1016/j.radonc.2011.07.012. View

Fokdal L, Sturdza A, Mazeron R, Haie-Meder C, Tan L, Gillham C . Image guided adaptive brachytherapy with combined intracavitary and interstitial technique improves the therapeutic ratio in locally advanced cervical cancer: Analysis from the retroEMBRACE study. Radiother Oncol. 2016; 120(3):434-440. DOI: 10.1016/j.radonc.2016.03.020. View

Kuncman L, Kozlowski S, Pietraszek A, Pietrzykowska-Kuncman M, Danielska J, Sobotkowski J . Highly conformal CT based surface mould brachytherapy for non-melanoma skin cancers of earlobe and nose. J Contemp Brachytherapy. 2016; 8(3):195-200. PMC: 4965504. DOI: 10.5114/jcb.2016.61066. View

Georg P, Lang S, Dimopoulos J, Dorr W, Sturdza A, Berger D . Dose-volume histogram parameters and late side effects in magnetic resonance image-guided adaptive cervical cancer brachytherapy. Int J Radiat Oncol Biol Phys. 2010; 79(2):356-62. DOI: 10.1016/j.ijrobp.2009.11.002. View

Marsiglia H, Baldeyrou P, Lartigau E, Briot E, Haie-Meder C, Le Chevalier T . High-dose-rate brachytherapy as sole modality for early-stage endobronchial carcinoma. Int J Radiat Oncol Biol Phys. 2000; 47(3):665-72. DOI: 10.1016/s0360-3016(00)00486-7. View

Skowronek J, Chichel A . Brachytherapy in breast cancer: an effective alternative. Prz Menopauzalny. 2015; 13(1):48-55. PMC: 4520341. DOI: 10.5114/pm.2014.41090. View

Viswanathan A, Beriwal S, De Los Santos J, Demanes D, Gaffney D, Hansen J . American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy. Brachytherapy. 2012; 11(1):47-52. PMC: 3489267. DOI: 10.1016/j.brachy.2011.07.002. View

10.

Naghavi A, Fernandez D, Mesko N, Juloori A, Martinez A, Scott J . American Brachytherapy Society consensus statement for soft tissue sarcoma brachytherapy. Brachytherapy. 2017; 16(3):466-489. DOI: 10.1016/j.brachy.2017.02.004. View

11.

Tormo A, Celada F, Rodriguez S, Botella R, Ballesta A, Kasper M . Non-melanoma skin cancer treated with HDR Valencia applicator: clinical outcomes. J Contemp Brachytherapy. 2014; 6(2):167-72. PMC: 4105643. DOI: 10.5114/jcb.2014.43247. View

12.

Dobelbower R, Montemaggi P . Brachytherapy for pancreatic cancer: a review. Hepatogastroenterology. 1996; 43(8):333-7. View

13.

Bartochowska A, Skowronek J, Wierzbicka M, Leszczynska M, Szyfter W . The role of high-dose-rate and pulsed-dose-rate brachytherapy in the management of recurrent or residual stomal tumor after total laryngectomy. Laryngoscope. 2012; 123(3):657-61. DOI: 10.1002/lary.23739. View

14.

Skowronek J, Piotrowski T, Mlynarczyk W, Ramlau R . Advanced tracheal carcinoma--a therapeutic significance of HDR brachytherapy in palliative treatment. Neoplasma. 2004; 51(4):313-8. View

15.

Fijuth J . HDR endobronchial brachytherapy in palliative and combined radical treatment of lung cancer. J Contemp Brachytherapy. 2017; 1(4):231-236. PMC: 5086491. View

16.

Alam M, Nanda S, Mittal B, Kim N, Yoo S . The use of brachytherapy in the treatment of nonmelanoma skin cancer: a review. J Am Acad Dermatol. 2011; 65(2):377-388. DOI: 10.1016/j.jaad.2010.03.027. View

17.

Chin J, Rumble R, Kollmeier M, Heath E, Efstathiou J, Dorff T . Brachytherapy for Patients With Prostate Cancer: American Society of Clinical Oncology/Cancer Care Ontario Joint Guideline Update. J Clin Oncol. 2017; 35(15):1737-1743. DOI: 10.1200/JCO.2016.72.0466. View

18.

Rijkmans E, Nout R, Rutten I, Ketelaars M, Neelis K, Laman M . Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy. Gynecol Oncol. 2014; 135(2):231-8. DOI: 10.1016/j.ygyno.2014.08.027. View

19.

Potter R, Haie-Meder C, Van Limbergen E, Barillot I, De Brabandere M, Dimopoulos J . Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics,.... Radiother Oncol. 2006; 78(1):67-77. DOI: 10.1016/j.radonc.2005.11.014. View

20.

Strnad V, Ott O, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T . 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast:.... Lancet. 2015; 387(10015):229-38. DOI: 10.1016/S0140-6736(15)00471-7. View